Event ·Official first-hand

OpenAI 收购 Orchestra Bio，将 AI 引入药物研发

OpenAI 宣布收购 Orchestra Bio，目标是把 AI 运营能力引入生命科学研发领域。交易完成后，OpenAI 将帮助生物制药团队加速药物开发流程、推进新疗法研究。这是 OpenAI 继多家科技公司并购之后在生命科学方向的一次布局。

Current read

OpenAI 把 Orchestra Bio 收进来了，以后做药的公司能用他们的 AI 加快药物研发，生物医药的朋友可以关注下。

11 sources57° AI heatLast updated 2026/10/20 00:00:00

Evidence

11 sources

Primary sourceOpenAI Blog

2026/10/20 00:00:00View source

Related source 1rohanpaul_ai

2026/10/20 18:58:27View source

Related source 2TestingCatalog

2026/10/20 18:21:43View source

Related source 3Mark Chen (OpenAI 研究)

2026/10/20 19:33:08View source

Related source 4techcrunch

2026/10/20 20:35:10View source

Related source 5kimmonismus

2026/10/20 21:21:35View source

Related source 6IT之家

2026/10/20 22:51:11View source

Related source 7Tech in Asia

2026/10/21 06:21:20View source

Related source 8Decoder

2026/10/21 08:32:54View source

Related source 9The Information

2026/10/18 13:30:01View source

Related source 10Latent.Space

2026/10/19 15:03:00View source

Conflict check

Dedup data only shows that these sources discuss the same event, not that they agree. There is no structured supporting or refuting evidence yet, so no conflict is inferred automatically.

Open the story